CN Patent

CN112592348B — 一种4-氨基吡咯并[2,1-f][1,2,4]三嗪的制备方法

Assigned to Nanjing Finetech Chemical Co ltd · Expires 2022-03-08 · 4y expired

What this patent protects

本发明涉及一种4‑氨基吡咯并[2,1‑f][1,2,4]三嗪的制备方法，具体涉及以1‑氨基‑1H‑吡咯‑2‑甲腈盐酸盐和硫脲为原料，经环合反应、脱硫反应两步高效合成4‑氨基吡咯并[2,1‑f][1,2,4]三嗪，本发明提供的4‑氨基吡咯并[2,1‑f][1,2,4]三嗪的制备方法是一种高收率、低成本、三废少、产品纯度好、适宜工业化的制备方法。

USPTO Abstract

本发明涉及一种4‑氨基吡咯并[2,1‑f][1,2,4]三嗪的制备方法，具体涉及以1‑氨基‑1H‑吡咯‑2‑甲腈盐酸盐和硫脲为原料，经环合反应、脱硫反应两步高效合成4‑氨基吡咯并[2,1‑f][1,2,4]三嗪，本发明提供的4‑氨基吡咯并[2,1‑f][1,2,4]三嗪的制备方法是一种高收率、低成本、三废少、产品纯度好、适宜工业化的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN112592348B
Jurisdiction
CN
Classification
—
Expires
2022-03-08
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Finetech Chemical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.